Shilpa Medicare Ltd registers Bengaluru facility with Ministry of Health, UAE

Shilpa Medicare Ltd's Bengaluru facility for manufacture and testing of Orodispersible films and Transdermal systems has been successfully registered with Ministry of Health, United Arab Emirates. This registration enables company to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization.

The facility is involved in manufacturing and testing of specialized dosage forms eg. Orodispersible Films and Transdermal systems. The facility is backed up with strong Research and Development of Orodispersible films and transdermal technologies. The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements. The facility has already been issued GMP by UK MHRA.

The facility also manufactures dietary supplements in orodispersible films and was registered with US FDA Food Facility registry. The facility is actively exporting dietary supplements to US Market.

Shares of Shilpa Medicare Limited was last trading in BSE at Rs. 237.95 as compared to the previous close of Rs. 238.70. The total number of shares traded during the day was 6674 in over 590 trades.

The stock hit an intraday high of Rs. 243.30 and intraday low of 231.10. The net turnover during the day was Rs. 1576641.00.

Source : Equity Bulls

Keywords

ShilpaMedicare INE790G01031 BengaluruFacility UAE MinistryofHealth Registration